Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avid Product Development is a product design, engineering, and additive manufacturing company focused on helping customers move from concept through prototyping to production. The company provides design for additive manufacturing, mechanical engineering, rapid prototyping, bridge manufacturing, post-processing, and 3D printing services using technologies such as HP Multi Jet Fusion, selective laser sintering, fused filament fabrication, stereolithography, and related finishing workflows. Although it serves some medical device customers, Avid Product Development is not a biotech, pharma, or healthcare therapeutics company; it is primarily an industrial product development and manufacturing-services business. The company was acquired by Lubrizol in 2020 and now operates as part of Lubrizol 3D Printing Solutions. Its capabilities are positioned across multiple end markets including medical device, aerospace, automotive, consumer goods, robotics, and industrial applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avid Product Development.